7 Type 2 Diabetes Clinical Trials in Scottsdale, AZ (2026)

Q: How do I join a clinical trial in Scottsdale?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Scottsdale research site will contact you.

Recruiting Type 2 Diabetes Studies in Scottsdale

NCT06112418Recruiting

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no k...

Scottsdale, AZNA7,500 participantsCleerly, Inc.

View Study Details

NCT05390892Recruiting

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients...

Scottsdale, AZPHASE46,000 participantsBrigham and Women's Hospital

View Study Details

NCT06628908Recruiting

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN)....

Scottsdale, AZPHASE31,100 participantsVertex Pharmaceuticals Incorporated

View Study Details

NCT07231419Recruiting

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine in participants with pain associated with diabetic peripheral neuropathy (DPN)....

Scottsdale, AZPHASE3734 participantsVertex Pharmaceuticals Incorporated

View Study Details

NCT07449923Recruiting

CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept....

Scottsdale, AZPHASE3240 participantsEyePoint Pharmaceuticals, Inc.

View Study Details

NCT07553429Recruiting

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

This study is open to adults with diabetic macular edema that involves the center of the eye. The purpose of this study is to find out how well different doses of a medicine called BI 3812465 are tole...

Scottsdale, AZPHASE149 participantsBoehringer Ingelheim

View Study Details

NCT07355270Recruiting

A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)

The purpose of this study is to assess the safety, tolerability and effectiveness of RF vapor ablation of the proximal intestinal mucosa. This study will test the hypothesis that RF vapor ablation wil...

Scottsdale, AZNA20 participantsAqua Medical, Inc.

View Study Details

About Type 2 Diabetes Clinical Trials in Scottsdale

Type 2 diabetes is a chronic metabolic condition affecting over 37 million Americans, characterized by insulin resistance and progressive loss of beta-cell function. While metformin remains the first-line treatment, the treatment landscape has expanded dramatically with GLP-1 receptor agonists (semaglutide, tirzepatide), SGLT2 inhibitors (empagliflozin, dapagliflozin), and dual GIP/GLP-1 agonists showing both glycemic and cardiovascular benefits. Clinical trials are now exploring triple-hormone agonists, oral GLP-1 formulations, islet cell regeneration therapies, and precision medicine approaches that tailor treatment to individual metabolic profiles. Patients with uncontrolled HbA1c on current medications, those with diabetic complications, or newly diagnosed patients may qualify for enrollment.

There are currently 7 type 2 diabetes clinical trials recruiting participants in Scottsdale, AZ. These studies are seeking a combined 15,643 participants. Research is being sponsored by Cleerly, Inc., Brigham and Women's Hospital, Vertex Pharmaceuticals Incorporated and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Type 2 Diabetes Clinical Trials in Scottsdale — FAQ

Are there type 2 diabetes clinical trials in Scottsdale?

Yes, there are 7 type 2 diabetes clinical trials currently recruiting in Scottsdale, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Scottsdale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Scottsdale research site will contact you about next steps.

Are clinical trials in Scottsdale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Scottsdale studies also compensate for your time and travel.

What type 2 diabetes treatments are being tested?

The 7 active trials in Scottsdale are testing new therapies including novel drugs, biologics, and treatment approaches for type 2 diabetes.

Data updated July 19, 2026 from ClinicalTrials.gov